SARCOIDOSIS
Clinical trials for SARCOIDOSIS explained in plain language.
Never miss a new study
Get alerted when new SARCOIDOSIS trials appear
Sign up with your email to follow new studies for SARCOIDOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Failed sarcoidosis study sought blood test to predict drug success
Symptom relief TerminatedThis study tested whether Acthar gel can improve symptoms and lung function in people with sarcoidosis, a disease that causes inflammation in the lungs. Researchers also checked if a blood marker called CXCL9 could predict who would benefit. Only 2 people enrolled before the stud…
Matched conditions: SARCOIDOSIS
Phase: PHASE4 • Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated May 26, 2026 03:11 UTC
-
Sarcoidosis drug study halted after just 3 patients
Knowledge-focused TerminatedThis study aimed to see if the drug maraviroc could reduce inflammation in the lungs of people with sarcoidosis. Participants took the drug for 6 weeks and had two lung exams to measure immune cells. The study was stopped early and only enrolled 3 people, so no clear conclusions …
Matched conditions: SARCOIDOSIS
Phase: NA • Sponsor: Kevin F. Gibson • Aim: Knowledge-focused
Last updated May 19, 2026 12:00 UTC